Stay updated on IMGN853 + Pembrolizumab in Endometrial Cancer Clinical Trial

Sign up to get notified when there's something new on the IMGN853 + Pembrolizumab in Endometrial Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the IMGN853 + Pembrolizumab in Endometrial Cancer Clinical Trial page

  1. Check
    3 days ago
    Change Detected
    Summary
    The site footer revision label changes from v3.7.2 to v3.8.0, while the page remains a 403 Forbidden error rather than displaying the study record.
    Difference
    0.2%
    Check dated 2026-11-02T13:53:36.000Z thumbnail image
  2. Check
    10 days ago
    Change Detected
    Summary
    A site-wide NIH notice announces updates and FAQs about the transition from “Artificial Intelligence” to “Super Intelligence” terminology.
    Difference
    1%
    Check dated 2026-10-26T15:37:52.000Z thumbnail image
  3. Check
    17 days ago
    Change Detected
    Summary
    The footer's site revision label changes from v3.7.1 to v3.7.2, while the study page remains an access-denied (403) page.
    Difference
    0.2%
    Check dated 2026-10-19T15:39:11.000Z thumbnail image
  4. Check
    24 days ago
    Change Detected
    Summary
    The site footer revision changes from v3.7.0 to v3.7.1 while the page remains a 403 error page.
    Difference
    0.2%
    Check dated 2026-10-12T15:47:47.000Z thumbnail image
  5. Check
    45 days ago
    Change Detected
    Summary
    The page now shows a 403 Forbidden error instead of the study details. This indicates access restrictions or a server issue affecting the display of the study record.
    Difference
    19%
    Check dated 2026-09-21T21:58:07.000Z thumbnail image
  6. Check
    66 days ago
    Change Detected
    Summary
    The page revision label was bumped from v3.6.5 to v3.6.6, representing a minor update; no visible changes to the study information or layout are evident.
    Difference
    0.1%
    Check dated 2026-08-31T17:12:42.000Z thumbnail image

Stay in the know with updates to IMGN853 + Pembrolizumab in Endometrial Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the IMGN853 + Pembrolizumab in Endometrial Cancer Clinical Trial page.